ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pi [Anatol J Cardiol]
Anatol J Cardiol. 2010; 10(3): 294-295 | DOI: 10.5152/akd.2010.079

The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pi

Ömer Yiğiner1, Fatih Özçelik2, Mustafa Aparcı1, Zafer Işılak1, Ömer Uz1
1Cardiology Division, Gülhane Military Medical Academy, Haydarpaşa Hospital, İstanbul
2Biochemistry Laboratory, Gümüşsuyu Military Hospital, İstanbul, Turkey

Ömer Yiğiner, Fatih Özçelik, Mustafa Aparcı, Zafer Işılak, Ömer Uz. The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pi. Anatol J Cardiol. 2010; 10(3): 294-295

Corresponding Author: Ömer Yiğiner, Türkiye
Manuscript Language: English
TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search
  1. Home
  2. About
  3. Abstrating and Indexing
  1. Copyright
  2. Aim and Scope
  3. Editorial Board
  1. Instructions for Authors
  2. ICMJE Recommendations
  3. Contact

Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media. 
LookUs  &   Online Makale